Skip to search formSkip to main contentSkip to account menu

Parathormone (human recombinant)

Known as: parathyroid hormone (1-84) human recombinant, rhPTH, rhPTH(1-84) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
The biomechanical properties of bone define skeletal fragility. Surrogates such as bone density or biochemical markers are used… 
Review
2013
Review
2013
OBJECTIVE To describe a case of hypocalcemia in a patient with a gain-of-function mutation in the calcium-sensing receptor that… 
2013
2013
SummaryThe secreted protein acidic and rich in cysteine (SPARC), also known as osteonectin, plays an important role in osteoblast… 
2012
2012
PURPOSE Intermittent administration of recombinant human PTH [rhPTH (1-34)] exerts an osteoanabolic effect characterized by… 
2012
2012
Background: The mechanisms regulating the anabolic response of the skeleton for recombinant human PTH (1–34) [rhPTH (1–34… 
Highly Cited
2010
Highly Cited
2010
SummaryThe level of increased bone formation after 24 months of treatment with teriparatide (rhPTH (1–34), TPTD) is similar in… 
2009
2009
SummaryThe current study was designed to determine the safety, tolerability and pharmacokinetic parameters of recombinant human… 
2008
2008
The aim of this study was to evaluate the effect of intermittent administration of human parathyroid hormone [rhPTH (1-34)] on… 
2008
2008
INTRODUCTION Teriparatide (recombinant human PTH 1-34/TPTD) is an osteoanabolic agent available for osteoporosis treatment. The…